​

Profound Medical (PROF) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PROF Stock Forecast

Profound Medical (PROF) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $11.00, with a high of $11.00 and a low of $11.00. This represents a 61.76% increase from the last price of $6.80.

$6 $7 $8 $9 $10 $11 High: $11 Avg: $11 Low: $11 Last Closed Price: $6.8

PROF Stock Rating

Profound Medical stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

PROF Price Target Upside V Benchmarks

TypeNameUpside
StockProfound Medical61.76%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks21.93%

Price Target Trends

1M3M12M
# Anlaysts-12
Avg Price Target-$11.00$11.50
Last Closing Price$6.80$6.80$6.80
Upside/Downside-61.76%69.12%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26-5---5
Aug, 26-5---5
Jul, 2614---5
Jun, 2614---5
May, 2614---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 27, 2026Strong BuyRaymond James$11.00$7.3350.07%61.76%
Jan 07, 2026Lake Street$12.00$7.9550.94%76.47%
Dec 02, 2024Ben HaynorLoop Capital Markets$17.00$8.03111.71%150.00%
Jul 23, 2024Ben HaynorLake Street$16.50$10.2860.51%142.65%
Jul 15, 2024Rick WiseStifel Nicolaus$12.00$9.1531.15%76.47%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 27, 2026Raymond JamesOutperformStrong Buyupgrade
Jan 07, 2026Lake StreetBuyBuyhold
Dec 02, 2024Lake StreetBuyBuyhold
Jan 06, 2023Lake StreetBuyBuyhold
Feb 22, 2022Raymond JamesOutperformdowngrade

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 $4 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.50$-1.38$-1.35$-1.07$1.41---
Avg Forecast$-1.62$-1.74$-1.63$-1.71$-1.32$-0.88$0.47$2.03
High Forecast$-1.04$-0.98$-1.51$-1.36$-0.36$-0.41$0.72$3.14
Low Forecast$-2.29$-2.51$-1.76$-1.88$-1.99$-1.37$0.22$0.95
Surprise %-7.41%-20.69%-17.18%-37.43%-206.82%---

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.87M$6.68M$7.20M$10.17M$16.10M---
Avg Forecast$9.56M$8.09M$7.11M$11.23M$26.94M$49.89M$98.28M$155.07M
High Forecast$12.60M$10.86M$10.09M$15.93M$35.00M$70.78M$139.44M$220.03M
Low Forecast$6.90M$5.39M$4.19M$6.62M$15.60M$29.41M$57.94M$91.43M
Surprise %-28.14%-17.42%1.24%-9.44%-40.24%---

Net Income Forecast

$-100M $-60M $-20M $20M $60M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-30.70M$-28.67M$-28.57M$-26.48M$42.32M---
Avg Forecast$-34.40M$-36.81M$-34.53M$-36.13M$-28.03M$-18.73M$9.89M$43.05M
High Forecast$-21.96M$-20.85M$-32.03M$-28.90M$-7.68M$-8.74M$15.28M$66.49M
Low Forecast$-48.60M$-53.21M$-37.32M$-39.90M$-42.24M$-28.93M$4.62M$20.08M
Surprise %-10.76%-22.11%-17.27%-26.70%-250.96%---

PROF Forecast FAQ

Is Profound Medical stock a buy?

Profound Medical stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Profound Medical is a favorable investment for most analysts.

What is Profound Medical's price target?

Profound Medical's price target, set by 7 Wall Street analysts, averages $11 over the next 12 months. The price target range spans from $11 at the low end to $11 at the high end, suggesting a potential 61.76% change from the previous closing price of $6.8.

How does Profound Medical stock forecast compare to its benchmarks?

Profound Medical's stock forecast shows a 61.76% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (21.93%).

What is the breakdown of analyst ratings for Profound Medical over the past three months?

  • September 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Profound Medical’s EPS forecast?

Profound Medical's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.88, marking a -162.41% decrease from the reported $1.41 in 2025. Estimates for the following years are $0.47 in 2027, and $2.03 in 2028.

What is Profound Medical’s revenue forecast?

Profound Medical's average annual revenue forecast for its fiscal year ending in December 2026 is $49.89M, reflecting a 209.90% increase from the reported $16.1M in 2025. The forecast for 2027 is $98.28M, and $155.08M for 2028.

What is Profound Medical’s net income forecast?

Profound Medical's net income forecast for the fiscal year ending in December 2026 stands at $-18.729M, representing a -144.26% decrease from the reported $42.32M in 2025. Projections indicate $9.89M in 2027, and $43.05M in 2028.